- Trials with a EudraCT protocol (6)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (0)
6 result(s) found for: Abscopal Effect.
Displaying page 1 of 1.
EudraCT Number: 2017-003334-82 | Sponsor Protocol Number: Uni-Koeln-3140 | Start Date*: 2019-03-11 | |||||||||||
Sponsor Name:University of Cologne | |||||||||||||
Full Title: Abscopal Effect of Radiotherapy and Nivolumab in anti-PD1 Pretreated Relapsed or Refractory classical Hodgkin Lymphoma - An international multicenter Phase II trial | |||||||||||||
Medical condition: Improvement of efficacy of nivolumab in patients with relapsed or refractory classical Hodgkin Lymphoma who recently progressed on anti-PD1 therapy. | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Completed) NO (Ongoing) NL (Ongoing) AT (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2017-000433-30 | Sponsor Protocol Number: UCL/17/0053 | Start Date*: 2018-05-23 | |||||||||||
Sponsor Name:University College London | |||||||||||||
Full Title: Phase II Trial of Pembrolizumab and Radiotherapy in Cutaneous T cell lymphoma | |||||||||||||
Medical condition: Cutaneous T cell lymphoma | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: GB (GB - no longer in EU/EEA) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2014-004065-25 | Sponsor Protocol Number: CCR4251 | Start Date*: 2015-07-28 |
Sponsor Name:Royal Marsden | ||
Full Title: Randomised Phase II Trial of Pembrolizumab and Radiotherapy in Melanoma | ||
Medical condition: Advanced or unresectable melanoma. | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: GB (GB - no longer in EU/EEA) | ||
Trial results: View results |
EudraCT Number: 2018-001032-22 | Sponsor Protocol Number: AGI-134.FIM.101 | Start Date*: 2019-01-21 |
Sponsor Name:Agalimmune Ltd. | ||
Full Title: A phase I/IIa, multicentre, open label study designed to evaluate the safety and tolerability of escalating doses of AGI-134 in unresectable/metastatic solid tumours. | ||
Medical condition: metastatic unresectable solid tumours | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: GB (GB - no longer in EU/EEA) | ||
Trial results: (No results available) |
EudraCT Number: 2021-001270-34 | Sponsor Protocol Number: RIMAL1 | Start Date*: 2021-04-19 | |||||||||||
Sponsor Name:Radboud University Medical Centre | |||||||||||||
Full Title: Enhancement of immune response by combining immune checkpoint blockade and radiation in patients with recurrent / refractory malignant lymphoma (re-directing the immune system). | |||||||||||||
Medical condition: patients with recurrent / refractory 9p24.1 amplified malignant lymphomas patients with recurrent / refractory malignant lymphoma without 9p24.1 amplification | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: NL (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2018-002583-11 | Sponsor Protocol Number: UM2018IMMUNOSABR2RLPL | Start Date*: 2019-12-12 | |||||||||||
Sponsor Name:Maastricht University Medical Centre | |||||||||||||
Full Title: Phase II study examining the activity of L19-IL2 immunotherapy and stereotactic ablative radiotherapy in metastatic non-small cell lung cancer | |||||||||||||
Medical condition: The trial will consist of one cohort of adult patients with Stage IV metastatic NSCLC | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: FR (Prematurely Ended) NL (Ongoing) BE (Ongoing) GB (GB - no longer in EU/EEA) IT (Ongoing) | |||||||||||||
Trial results: (No results available) |
Subscribe to this Search
To subscribe to the RSS feed for this search click here . This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here . This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
Download Options: | |
---|---|
Number of Trials to download: | |
Download Content: | |
Download Format: | |
Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. |
Query did not match any studies.